ARCHIVES

ASCO Briefing Highlights Seven Studies That Could Change Clinical Practice

This article is from The Cancer Letter archive.

Vol. 32 No. 5 | May 29, 2009

Download PDF Visit The Full Archive

Related Articles

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000

NCI Takes Action Against Investigators Who Gave Drug Without An IND; M.D. Anderson Contract Canceled

August 28, 1981

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

November 19, 1976

In Congress: $135 Million Expected For DOD Breast Cancer Research Program

July 24, 1998

ASCO Foundation Renamed

February 18, 2011

Bill Reintroduced to Weaken U.S. Preventive Services Task Force

July 3, 2013